Sallman, David A.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis

Castillo-Tokumori, Franco, Talati, Chetasi, Al Ali, Najla, Sallman, David, Yun, Seongseok, Sweet, Kendra, Padron, Eric, Lancet, Jeffrey, Komrokji, Rami, Kuykendall, Andrew T.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2020

File:

PDF, 495 KB

2020

2

Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype

Schwabkey, Zaker I., Al Ali, Najla, Chan, Onyee, Sallman, David A., Padron, Eric, Kuykendall, Andrew T., Talati, Chetasi, Sweet, Kendra, Lancet, Jeffrey E., Komrokji, Rami S.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2020

File:

PDF, 560 KB

2020

3

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study

Gillis, Nancy K, Ball, Markus, Zhang, Qing, Ma, Zhenjun, Zhao, YuLong, Yoder, Sean J, Balasis, Maria E, Mesa, Tania E, Sallman, David A, Lancet, Jeffrey E, Komrokji, Rami S, List, Alan F, McLeod, Howa

Journal:

The Lancet Oncology

Year:

2016

Language:

english

File:

PDF, 377 KB

english, 2016

4

Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes

Melody, Megan, Al Ali, Najla, Zhang, Ling, Ramadan, Hanadi, Padron, Eric, Sallman, David, Sweet, Kendra, Lancet, Jeffrey, List, Alan, Bennett, John M., Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2020

File:

PDF, 322 KB

2020

5

Novel therapies in myelodysplastic syndromes

Swoboda, David M., Gesiotto, Quinto, Sallman, David A.

Journal:

Current Opinion in Hematology

Year:

2020

Language:

english

File:

PDF, 238 KB

english, 2020

6

Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond

Talati, Chetasi, Sallman, David, List, Alan

Journal:

Seminars in Hematology

Year:

2017

Language:

english

File:

PDF, 882 KB

english, 2017

7

Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes

McGraw, Kathy L., Nguyen, Johnny, Al Ali, Najla H., Komrokji, Rami S., Sallman, David, Zhang, Xiaohui, Song, Jinming, Padron, Eric, Lancet, Jeffrey E., Moscinski, Lynn C., List, Alan F., Zhang, Ling

Journal:

British Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 789 KB

english, 2018

8

TP53 and Therapy-related Myeloid Neoplasms

Chung, Jae, Sallman, David A., Padron, Eric

Journal:

Best Practice & Research Clinical Haematology

Year:

2019

Language:

english

File:

PDF, 968 KB

english, 2019

9

To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia

Sallman, David A.

Journal:

Year:

2020

File:

PDF, 3.13 MB

2020

10

T-Cell Large Granular Lymphocyte Proliferation (LGL) in Patients with Myelodysplastic Syndromes (MDS): Not an Innocent Bystander?

Roe, Christa, Ali, Najla, Epling-Burnette, P.K., Bennett, Janice, Padron, Eric, Sallman, David, Sokol, Lubomir, Lancet, Jeffrey, List, Alan, Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2016

Language:

english

File:

PDF, 63 KB

english, 2016

11

S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes

Cheng, Pinyang, Eksioglu, Erika A., Chen, Xianghong, Kandell, Wendy, Le Trinh, Thu, Cen, Ling, Qi, Jin, Sallman, David A., Zhang, Yu, Tu, Nhan, Adams, William A., Zhang, Chunze, Liu, Jinhong, Clevelan

Journal:

Year:

2019

File:

PDF, 1.58 MB

2019

12

Specific Binding Site for Pro Atrial IMatriuretic Factors 1-30, 31-67, and 99-126 on Distal Nephrons, Proximal Tubules, Renal Cortical and Medullary Membranes

Vesely, David L., Sallman, Alan L., Bayliss, John M.

Journal:

Kidney & Blood Pressure Research

Year:

1992

Language:

english

File:

PDF, 1.58 MB

english, 1992

13

Driver Mutation‐Specific Clinical and Genomic Correlates Differ Between Primary and Secondary Myelofibrosis

Kuykendall, Andrew T., Talati, Chetasi, Padron, Eric, Sweet, Kendra, Lancet, Jeffrey E., List, Alan F, Sallman, David, Komrokji, Rami S.

Journal:

American Journal of Hematology

Year:

2019

Language:

english

File:

PDF, 1.42 MB

english, 2019

14

Lenalidomide and Thalidomide are Active in MF-Related Anemia, but Differ in Duration of Response and Association of Benefit with Outcome

Kuykendall, Andrew, Talati, Chetasi, Padron, Eric, Sweet, Kendra, Sallman, David, List, Alan, Lancet, Jeffrey, Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 71 KB

english, 2019

15

Targeting TP53 Mutations in Myelodysplastic Syndromes

Hunter, Anthony M., Sallman, David A.

Journal:

Hematology/Oncology Clinics of North America

Year:

2019

File:

PDF, 474 KB

2019

16

A sequential two-stage dose escalation study of eltrombopag in patients with myelodysplastic syndrome and thrombocytopenia after hypomethylating agent failure

Duong, Vu H., Al Ali, Najla, Zhang, Ling, Padron, Eric, Sallman, David, Lancet, Jeffrey E., List, Alan F., Komrokji, Rami S.

Journal:

Leukemia and Lymphoma

Year:

2020

File:

PDF, 886 KB

2020

17

PP2A: The Achilles Heal in MDS with 5q Deletion

Sallman, David A., Wei, Sheng, List, Alan

Journal:

Frontiers in Oncology

Year:

2014

Language:

english

File:

PDF, 713 KB

english, 2014

18

Comparing Eras in Myelofibrosis: Changing Patterns of Treatment Before and After FDA-Approval of Ruxolitinib

Kuykendall, Andrew, Al Ali, Najla, Talati, Chetasi, Padron, Eric, Sallman, David, Lancet, Jeffrey, List, Alan, Zuckerman, Kenneth, Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2016

Language:

english

File:

PDF, 331 KB

english, 2016

19

Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype

Sallman, David A., Cluzeau, Thomas, Basiorka, Ashley A., List, Alan

Journal:

Frontiers in Oncology

Year:

2016

Language:

english

File:

PDF, 1.53 MB

english, 2016

20

When Two Roads Diverge: Genetically Inspired Prognostic Scoring System (GIPSS) Outperforms DIPSS in Myelofibrosis Patients where the Two Risk Models Widely Differ

Kuykendall, Andrew, Talati, Chetasi, Padron, Eric, Sweet, Kendra, Sallman, David, List, Alan F., Lancet, Jeffrey E., Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 69 KB

english, 2018

21

A Phase 2 Trial of the Oral Smoothened Inhibitor Glasdegib in Refractory Myelodysplastic Syndromes (MDS)

Sallman, David A., Komrokji, Rami S, Sweet, Kendra L., Mo, Qianxing, McGraw, Kathy L, Duong, Vu H., Zhang, Ling, Nardelli, Lisa Ann, Padron, Eric, List, Alan F, Lancet, Jeffrey E.

Journal:

Leukemia Research

Year:

2019

Language:

english

File:

PDF, 410 KB

english, 2019

22

Case Presentation: Managing TP53-Mutant MDS

Sallman, David A.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 55 KB

english, 2019

23

The effect of thymine starvation on chromosomal structure of escherichia coli JG-151

David L. Reichenbach, George E. Schaiberger, Bennett Sallman

Journal:

Biochemical and Biophysical Research Communications

Year:

1971

Language:

english

File:

PDF, 357 KB

english, 1971

24

Prognostic Significance of Serial Molecular Annotation in Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)

Yun, Seongseok, Komrokji, Rami, Al Ali, Najla, Song, Jinming, Vaupel, Christine, Hussaini, Mohammad, Sweet, Kendra, Lancet, Jeffrey, Hall, Jeff, List, Alan, Padron, Eric, Sallman, David

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 87 KB

english, 2017

25

Defining Acute Myeloid Leukemia Ontogeny in Older Patients

Melody, Megan, Sallman, David, AlAli, Najla, Ramadan, Hanadi, Zhang, Ling, Padron, Eric, Sweet, Kendra, Extermann, Martine, List, Alan, Lancet, Jeffery, Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 59 KB

english, 2017

26

ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS

Sallman, David A, Komrokji, Rami, Cluzeau, Thomas, Vaupel, Christine, Al Ali, Najla H, Lancet, Jeffrey, Hall, Jeff, List, Alan, Padron, Eric, Song, Jinming

Journal:

Blood Cancer Journal

Year:

2017

Language:

english

File:

PDF, 396 KB

english, 2017

27

Obesity Impact on Outcomes of Myelodysplastic Syndromes

Al Ali, Najla, Sallman, David, Padron, Eric, Lancet, Jeffery, List, Alan, Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 66 KB

english, 2018

28

Increased Circulating Concentration of the N-Terminus of the Atrial Natriuretic Factor Prohormone in Persons with Pheochromocytomas*

VESELY, DAVID L., ARNOLD, WATSON C., WINTERS, CHRIS J., SALLMAN, ALAN L., RICO, DAVID M.

Journal:

Journal of Clinical Endocrinology & Metabolism

Year:

1990

Language:

english

File:

PDF, 1.48 MB

english, 1990

29

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.

Sallman, David A., Brayer, Jason, Sagatys, Elizabeth M., Lonez, Caroline, Breman, Eytan, Agaugué, Sophie, Verma, Bikash, Gilham, David E., Lehmann, Frédéric F., Davila, Marco L.

Journal:

Year:

2018

Language:

english

File:

PDF, 1.17 MB

english, 2018

30

A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes

Komrokji, Rami S., Wei, Sheng, Mailloux, Adam W., Zhang, Ling, Padron, Eric, Sallman, David, Lancet, Jeffrey E., Tinsley, Sara, Nardelli, Lisa A., Pinilla-Ibarz, Javier, Epling-Burnette, Pearlie K., L

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

File:

PDF, 572 KB

2018

31

Validation of International Working Group response criteria in higherârisk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium

Komrokji, Rami S., Al Ali, Najla H, Sallman, David, Padron, Eric, DeZern, Amy E., Barnard, John, Roboz, Gail J., GarciaâManero, Guillermo, List, Alan, Steensma, David P., Sekeres, Mikkael A.

Journal:

Cancer Medicine

Year:

2020

File:

PDF, 269 KB

2020

32

Exercise increases the circulating concentration of the N-terminus of the atrial natriuretic factor prohormone in normal individuals

Bonnie J. Baker, William C.L. Wu, Chris J. Winters, Ha Dinh, Richard Wyeth, Alan L. Sallman, David L. Vesely

Journal:

American Heart Journal

Year:

1991

Language:

english

File:

PDF, 1.35 MB

english, 1991

33

Chromosomal 3 Abnormalities in Myelodysplastic Syndromes: Implications on Prognosis and Response to Treatment

Sallman, David, Al Ali, Najla, Padron, Eric, Lancet, Jeffrey, List, Alan, Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2015

Language:

english

File:

PDF, 58 KB

english, 2015

34

Pharmacokinetic Characterization of the Postdistribution Phase of Prohormone Atrial Natriuretic Peptides Amino Acids 1-98, 31-67, and Atrial Natriuretic Factor During and After Rapid Right Ventricular Pacing in Dogs

Ackerman, Bruce H., Wyeth, Richard P., Vesely, David L., Ngo, William L., Bissett, Joe K., Winters, Chris J., Sallman, Alan L.

Journal:

Journal of Clinical Pharmacology

Year:

1992

Language:

english

File:

PDF, 1.06 MB

english, 1992

35

Lenalidomide is Effective Treatment Option for Patients with Refractory Anemia with Ring Sideroblasts and Thrombocytosis

Melody, Megan, Al Alu, Najla, Sallman, David, Padron, Eric, List, Alan, Lancet, Jeffery, Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 67 KB

english, 2018

36

Two new hormones: Prohormone atrial natriuretic peptides 1–30 and 31–67 circulate in man

Chris J. Winters, Alan L. Sallman, Jane Meadows, David M. Rico, David L. Vesely

Journal:

Biochemical and Biophysical Research Communications

Year:

1988

Language:

english

File:

PDF, 423 KB

english, 1988

37

The N-Terminus of the Atrial Natriuretic Factor Prohormone in the Pleural Fluid of Congestive Heart Failure Patients

Vesely, David L., Winters, Chris J., Sallman, Alan L.

Journal:

Year:

1990

Language:

english

File:

PDF, 876 KB

english, 1990

38

The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval

Kuykendall, Andrew T., Talati, Chetasi, Al Ali, Najla, Sweet, Kendra, Padron, Eric, Sallman, David A., Lancet, Jeffrey E., List, Alan F., Zuckerman, Kenneth S., Komrokji, Rami S.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 405 KB

english, 2017

39

Monocytosis in myelofibrosis is associated with clinical outcome, hematologic abnormalities and somatic mutations

Kerr, Daniel, Kuykendall, Andrew, Talati, Chetasi, Al-Ali, Najla, Sallman, David, Sweet, Kendra, Lancet, Jeffrey, List, Alan, Padron, Eric, Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 90 KB

english, 2017

40

Increased plasma concentration of atrial natriuretic factor with squamous cell carcinoma invasion of the right and left atria of the heart

Dan S. Bradford, Michael Keppen, Alan L. Sallman, Ha Dinh, David L. Vesely

Journal:

Year:

1989

Language:

english

File:

PDF, 442 KB

english, 1989

41

Myelodysplastic/Myeloproliferative Neoplasms Unclassified (MDS/MPN-U) Overlap: Impact of Hypomethylating Agents?

Hendrix, Kaitlin, Al Ali, Najla, Padron, Eric, Sallman, David, List, Alan, Lancet, Jeffrey, Komrokji, Rami

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2016

Language:

english

File:

PDF, 60 KB

english, 2016

42

Clinical Significance of MYC Oncoprotein Expression on Survival Outcome in Secondary Acute Myeloid Leukemia (sAML)

Yun, Seongseok, Sharma, Rohit, Chan, Onyee, Vincelette, Nicole, Sallman, David, Sweet, Kendra, Padron, Eric, Komrokji, Rami, Lancet, Jeffrey, Moscinski, Lynn, Cleveland, John, List, Alan, Zhang, Ling

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 95 KB

english, 2019

43

Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome

Badaat, Ibraahim, Mirza, Sabbir, Padron, Eric, Sallman, David, Komrokji, Rami, Song, Jinming, Hussaini, Mohammad O

Journal:

Journal of Clinical Pathology

Year:

2019

File:

PDF, 217 KB

2019

44

Lenalidomide and Prednisone in Low and Intermediate-1 IPSS Risk, Non-Del(5q) Patients With Myelodysplastic Syndromes: Phase 2 Clinical Trial

Komrokji, Rami S., Al Ali, Najla H., Padron, Eric, Cogle, Christopher, Tinsley, Sara, Sallman, David, Lancet, Jeffrey E., Lis, Alan F.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 147 KB

english, 2019

45

RUNX1 Mutation is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia (AML) who Received Allogeneic Stem Cell Transplantation (allo-SCT)

Chan, Onyee, Jennings, Michelle, Asghari, Hannah, Song, Jinming, Hussaini, Mohammad, Sallman, David, Padron, Eric, Komrokji, Rami, List, Alan, Lancet, Jeffrey, Mishra, Asmita, Sweet, Kendra, Talati, C

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 71 KB

english, 2019

46

Critical evaluation of the FANTOM3 non-coding RNA transcripts

Karl J.V. Nordström, Majd A.I. Mirza, Markus Sällman Almén, David E. Gloriam, Robert Fredriksson, Helgi B. Schiöth

Journal:

Year:

2009

Language:

english

File:

PDF, 323 KB

english, 2009

47

What are the most promising new agents in acute myeloid leukemia?

Sallman, David A., Lancet, Jeffrey E.

Journal:

Current Opinion in Hematology

Year:

2017

Language:

english

File:

PDF, 351 KB

english, 2017

48

Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study

Basiorka, Ashley A, McGraw, Kathy L, Abbas-Aghababazadeh, Farnoosh, McLemore, Amy F, Vincelette, Nicole D, Ward, Grace A, Eksioglu, Erika A, Sallman, David A, Ali, Najla Al, Padron, Eric, Pinilla-Ibar

Journal:

The Lancet Haematology

Year:

2018

Language:

english

File:

PDF, 1021 KB

english, 2018

49

SOHO State of the Art and Next Questions: Management of Myelodysplastic Syndromes With Deletion 5q

Talati, Chetasi, Sallman, David, List, Alan F.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 609 KB

english, 2018

50

Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes

Badar, Talha, Szabo, Aniko, Sallman, David, Komrojki, Rami, Lancet, Jefferey, Padron, Eric, Song, Jinming, Hussaini, Mohammad Omar

Journal:

Leukemia and Lymphoma

Year:

2020

File:

PDF, 1.77 MB

2020

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски